首页 > 最新文献

Khirurgiya最新文献

英文 中文
[Eversion endarterectomy from common femoral artery bifurcation]. [股总动脉分叉处内翻性内膜剥脱术]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia2024101135
I P Mikhailov, V A Arustamyan, I A Eroshkin, B V Kozlovsky, E V Kungurtsev

Common femoral artery (CFA) bifurcation is a critical arterial segment of the lower extremities. Dos Santos J.C. first described endarterectomy from CFA in 1946. It is still preferable method for many patients with occlusion of CFA bifurcation. Although this technique is common in carotid artery surgery and much less common for atherosclerotic lesion of CFA bifurcation, some authors describe favorable results after eversion endarterectomy. Eversion endarterectomy is preferable if synthetic material and autologous veins are unavailable for repair.

股总动脉(CFA)分叉处是下肢的重要动脉段。多斯桑托斯-J.C.于1946年首次描述了股总动脉内膜切除术。对于许多闭塞 CFA 分叉的患者来说,这仍然是一种可取的方法。虽然这种技术在颈动脉手术中很常见,但对于 CFA 分叉处的动脉粥样硬化病变却不常见,一些作者描述了外翻内膜切除术后的良好效果。如果无法使用合成材料和自体静脉进行修复,最好采用内翻动脉内膜切除术。
{"title":"[Eversion endarterectomy from common femoral artery bifurcation].","authors":"I P Mikhailov, V A Arustamyan, I A Eroshkin, B V Kozlovsky, E V Kungurtsev","doi":"10.17116/hirurgia2024101135","DOIUrl":"https://doi.org/10.17116/hirurgia2024101135","url":null,"abstract":"<p><p>Common femoral artery (CFA) bifurcation is a critical arterial segment of the lower extremities. Dos Santos J.C. first described endarterectomy from CFA in 1946. It is still preferable method for many patients with occlusion of CFA bifurcation. Although this technique is common in carotid artery surgery and much less common for atherosclerotic lesion of CFA bifurcation, some authors describe favorable results after eversion endarterectomy. Eversion endarterectomy is preferable if synthetic material and autologous veins are unavailable for repair.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 10","pages":"135-142"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Small pelvis lipoma spreading to the gluteal region]. [小骨盆脂肪瘤扩散至臀部区域]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202401197
V I Panteleev, A G Kriger, A O Gushcha, M M Dzhigkaeva

We present a 36-year-old woman with small pelvis lipoma spreading to the gluteal region through the greater sciatic foramen. Resection of lipoma was performed via two accesses (lower median laparotomy and semilunar incision in the gluteal region). The tumor was the content of sciatic hernia that is extremely rare. Combination of surgical approaches can provide favorable outcomes in these patients.

我们为一位 36 岁的女性介绍了通过坐骨大孔扩散到臀部的小骨盆脂肪瘤。脂肪瘤切除术通过两个切口(下正中开腹和臀部半月切口)进行。肿瘤是坐骨神经疝的内容物,这种情况极为罕见。对这类患者来说,联合手术方法可取得良好的疗效。
{"title":"[Small pelvis lipoma spreading to the gluteal region].","authors":"V I Panteleev, A G Kriger, A O Gushcha, M M Dzhigkaeva","doi":"10.17116/hirurgia202401197","DOIUrl":"10.17116/hirurgia202401197","url":null,"abstract":"<p><p>We present a 36-year-old woman with small pelvis lipoma spreading to the gluteal region through the greater sciatic foramen. Resection of lipoma was performed via two accesses (lower median laparotomy and semilunar incision in the gluteal region). The tumor was the content of sciatic hernia that is extremely rare. Combination of surgical approaches can provide favorable outcomes in these patients.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 1","pages":"97-101"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139521961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endovascular treatment of deep vein thrombosis of the upper extremities]. [上肢深静脉血栓的血管内治疗]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202402145
B S Sukovatykh, A V Sereditsky, V F Muradyan, M B Sukovatykh, N V Bolomatov, M Y Gordov

Objective: To improve the results of treatment of deep vein thrombosis of the upper extremities sing endovascular technologies.

Material and methods: We analyzed safety and effectiveness of treatment in 24 patients with deep vein thrombosis of the upper extremities. All ones were divided into 2 homogeneous groups by 12 people each. In the first group, conventional anticoagulation was performed. In the second group, we used additional regional catheter thrombolysis with alteplase and, if necessary, venous stenting or balloon angioplasty for residual stenosis. Patients received apixaban at baseline and throughout 6 postoperative months. After 12 months, we performed ultrasound and clinical examination to identify deep vein patency and venous outflow disorders. Vein recanalization was evaluated as follows: <50% - minimal, 50-99% - partial, 100% - complete. The quality of life of patients was studied using the SF-36 questionnaire.

Results: In the first group, we observed complete vein recanalization in 25% of cases, partial - in 33%, minimal - in 41% of cases; in the second group - 83.3% and 16.7% of patients, respectively. In the first group, clinical manifestations of venous outflow disorders were absent in 25% of patients, mild disorders - 25%, moderate - 8.3%, severe - 41.7% of patients. In the second group, venous outflow was not impaired in 83.7% of patients, mild violations occurred in 16.7% of patients. In the first group, physical health was equal to 44.2±1.7 scores, psychological health - 49.3±2.3 scores; in the second group - 69.3±5.7 and 71.3±5.4 scores, respectively.

Conclusion: Endovascular treatment improved postoperative outcomes.

目的提高上肢深静脉血栓形成的治疗效果:我们对 24 名上肢深静脉血栓患者的治疗安全性和有效性进行了分析。所有患者分为两组,每组 12 人。第一组进行常规抗凝治疗。在第二组中,我们使用阿替普酶进行额外的区域导管溶栓治疗,如有必要,还对残余狭窄进行静脉支架或球囊血管成形术。患者在基线和术后 6 个月内接受阿哌沙班治疗。12 个月后,我们通过超声波和临床检查确定深静脉通畅情况和静脉流出障碍。静脉再通畅情况评估如下:结果在第一组患者中,我们观察到25%的患者静脉完全再通,33%的患者部分再通,41%的患者极少再通;在第二组患者中,分别观察到83.3%和16.7%的患者静脉再通。在第一组患者中,25%的患者没有静脉流出障碍的临床表现,25%的患者有轻度静脉流出障碍,8.3%的患者有中度静脉流出障碍,41.7%的患者有重度静脉流出障碍。在第二组中,83.7%的患者静脉外流未受损,16.7%的患者出现轻度障碍。第一组患者的身体健康评分为(44.2±1.7)分,心理健康评分为(49.3±2.3)分;第二组患者的身体健康评分为(69.3±5.7)分,心理健康评分为(71.3±5.4)分:结论:血管内治疗改善了术后效果。
{"title":"[Endovascular treatment of deep vein thrombosis of the upper extremities].","authors":"B S Sukovatykh, A V Sereditsky, V F Muradyan, M B Sukovatykh, N V Bolomatov, M Y Gordov","doi":"10.17116/hirurgia202402145","DOIUrl":"10.17116/hirurgia202402145","url":null,"abstract":"<p><strong>Objective: </strong>To improve the results of treatment of deep vein thrombosis of the upper extremities sing endovascular technologies.</p><p><strong>Material and methods: </strong>We analyzed safety and effectiveness of treatment in 24 patients with deep vein thrombosis of the upper extremities. All ones were divided into 2 homogeneous groups by 12 people each. In the first group, conventional anticoagulation was performed. In the second group, we used additional regional catheter thrombolysis with alteplase and, if necessary, venous stenting or balloon angioplasty for residual stenosis. Patients received apixaban at baseline and throughout 6 postoperative months. After 12 months, we performed ultrasound and clinical examination to identify deep vein patency and venous outflow disorders. Vein recanalization was evaluated as follows: <50% - minimal, 50-99% - partial, 100% - complete. The quality of life of patients was studied using the SF-36 questionnaire.</p><p><strong>Results: </strong>In the first group, we observed complete vein recanalization in 25% of cases, partial - in 33%, minimal - in 41% of cases; in the second group - 83.3% and 16.7% of patients, respectively. In the first group, clinical manifestations of venous outflow disorders were absent in 25% of patients, mild disorders - 25%, moderate - 8.3%, severe - 41.7% of patients. In the second group, venous outflow was not impaired in 83.7% of patients, mild violations occurred in 16.7% of patients. In the first group, physical health was equal to 44.2±1.7 scores, psychological health - 49.3±2.3 scores; in the second group - 69.3±5.7 and 71.3±5.4 scores, respectively.</p><p><strong>Conclusion: </strong>Endovascular treatment improved postoperative outcomes.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 2","pages":"45-51"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of indocyanine green plasma disappearance rate in clinical practice]. [吲哚菁绿血浆消失率在临床实践中的分析]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia20240225
V V Osovskikh, L N Kiseleva, I N Kolokolnikov, M S Vasilieva, A E Bautin

Objective: To justify the optimal method for determining indocyanine green plasma disappearance rate (PDRICG).

Material and methods: We analyzed PDRICG in intensive care units. Indocyanine green was administered intravenously at a dose of 0.25 mg/kg. PDRICG was analyzed simultaneously by using of three methods: 1) PDD (PiCCO2 LiMON device), 2) SBS with analysis of plasma samples on precise spectrophotometer, 3) SBS with analysis of plasma samples on simple experimental photometer.

Results: PDD method was used for 346 PDRICG tests in 256 patients. Of these, 14.3% of measurements were erroneous. Paired tests using PDD and SBS methods were performed in 299 cases. SBS method resulted erroneous data in 0.6% of cases. Certain correlation (r=0.79, p<0.001) was found between the reference method (SBS with spectrophotometry) and the PDD method. Bland-Altman plot for these two methods showed that proportional bias of mean difference was caused by extremely high PDRICG of the PDD method (for example, more than 30%/min). Comparison of two SBS variants (spectrophotometer and experimental photometer) revealed good correlation (r=0.91, p<0.001).

Conclusion: SBS method for measuring PDRICG ensures accurate results under mechanical interferences in patients with impaired capillary blood flow. This eliminates the need for redo measurement. Duplication of the PDD and SBS methods is recommended when repeating the test is not possible (organ donors).

目的:论证测定吲哚菁绿血浆消失率(PDRICG)的最佳方法:证明测定吲哚菁绿血浆消失率(PDRICG)的最佳方法:我们分析了重症监护病房的 PDRICG。吲哚菁绿的静脉注射剂量为 0.25 mg/kg。同时使用三种方法分析 PDRICG:1)PDD(PiCCO2 LiMON 装置);2)SBS,使用精密分光光度计分析血浆样本;3)SBS,使用简易实验光度计分析血浆样本:结果:256 名患者的 346 次 PDRICG 检测使用了 PDD 方法。其中,14.3%的测量出现错误。使用 PDD 和 SBS 方法对 299 例患者进行了配对测试。SBS 方法导致 0.6% 的病例出现数据错误。PDD 方法的 pICG 具有一定的相关性(例如,超过 30%/分钟)(r=0.79)。两种 SBS 变体(分光光度计和实验光度计)的比较显示出良好的相关性(r=0.91,pCG):在毛细血管血流受损的患者中,SBS 测量 PDRICG 的方法可确保在机械干扰下得出准确的结果。这消除了重做测量的需要。如果无法重复测试(器官捐献者),建议重复使用 PDD 和 SBS 方法。
{"title":"[Analysis of indocyanine green plasma disappearance rate in clinical practice].","authors":"V V Osovskikh, L N Kiseleva, I N Kolokolnikov, M S Vasilieva, A E Bautin","doi":"10.17116/hirurgia20240225","DOIUrl":"10.17116/hirurgia20240225","url":null,"abstract":"<p><strong>Objective: </strong>To justify the optimal method for determining indocyanine green plasma disappearance rate (PDR<sub>ICG</sub>).</p><p><strong>Material and methods: </strong>We analyzed PDR<sub>ICG</sub> in intensive care units. Indocyanine green was administered intravenously at a dose of 0.25 mg/kg. PDR<sub>ICG</sub> was analyzed simultaneously by using of three methods: 1) PDD (PiCCO2 LiMON device), 2) SBS with analysis of plasma samples on precise spectrophotometer, 3) SBS with analysis of plasma samples on simple experimental photometer.</p><p><strong>Results: </strong>PDD method was used for 346 PDR<sub>ICG</sub> tests in 256 patients. Of these, 14.3% of measurements were erroneous. Paired tests using PDD and SBS methods were performed in 299 cases. SBS method resulted erroneous data in 0.6% of cases. Certain correlation (<i>r</i>=0.79, <i>p</i><0.001) was found between the reference method (SBS with spectrophotometry) and the PDD method. Bland-Altman plot for these two methods showed that proportional bias of mean difference was caused by extremely high PDR<sub>ICG</sub> of the PDD method (for example, more than 30%/min). Comparison of two SBS variants (spectrophotometer and experimental photometer) revealed good correlation (<i>r</i>=0.91, <i>p</i><0.001).</p><p><strong>Conclusion: </strong>SBS method for measuring PDR<sub>ICG</sub> ensures accurate results under mechanical interferences in patients with impaired capillary blood flow. This eliminates the need for redo measurement. Duplication of the PDD and SBS methods is recommended when repeating the test is not possible (organ donors).</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 2. Vyp. 2","pages":"5-12"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139913595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Direct transfistulous ultrasound in minimally invasive surgical treatment of infected pancreatic necrosis]. [感染性胰腺坏死微创手术治疗中的直接输血超声]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202404138
S I Remizov, A V Andreev, V M Durleshter, S A Gabriel, O V Zasyadko

Objective: To develop a method for direct transfistulous ultrasound in minimally invasive treatment of infected pancreatic necrosis.

Material and methods: There were 148 patients with infected pancreatic necrosis between 2015 and 2019 at the Krasnodar City Clinical Hospital No. 2. Drainage with 28-32 Fr tubes was carried out at the first stage, endoscopic transfistulous sequestrectomy - at the second stage (19 (12.8%) patients). In 84 (56.8%) patients, we applied original diagnostic method (transfistulous ultrasonic assessment of inflammatory focus).

Results: There were 3 accesses to omental bursa in 93 (62.8%) patients and 2 in 43 (29.1%) patients. We also performed 2 access to retroperitoneal space in 63 (42.6%) patients and 1 access in 38 (25.8%) cases. Transfistulous ultrasound was used once in 19 (22.6%) patients, twice in 28 (33.3%) and 3 times in 37 (44.1%) patients. Examination was not performed in 18 (12.2%) patients due to the following reasons: migration of drainage catheters - 5, non-rectilinear fistulous tract - 13. No complications were observed.

Conclusion: Transfistulous ultrasound makes it possible to diagnose pathological changes in the pancreas and parapancreatic tissue at various stages of surgical treatment.

目的材料与方法:克拉斯诺达尔市第二临床医院2015年至2019年间共收治148例感染性胰腺坏死患者。在第一阶段使用 28-32 Fr 管进行引流,在第二阶段进行内镜下经瘘管切除术(19 例(12.8%)患者)。在 84 例(56.8%)患者中,我们采用了最初的诊断方法(经皮超声波评估炎症病灶):结果:93 例(62.8%)患者中有 3 例进入网膜囊,43 例(29.1%)患者中有 2 例进入网膜囊。我们还对 63 例(42.6%)患者的腹膜后间隙进行了 2 次探查,对 38 例(25.8%)患者进行了 1 次探查。19例(22.6%)患者使用过一次输卵管超声检查,28例(33.3%)患者使用过两次,37例(44.1%)患者使用过三次。18例(12.2%)患者因以下原因未进行检查:引流导管移位--5例,非直角瘘管--13例。未发现并发症:结论:经瘘管超声检查可诊断手术治疗不同阶段胰腺和胰旁组织的病理变化。
{"title":"[Direct transfistulous ultrasound in minimally invasive surgical treatment of infected pancreatic necrosis].","authors":"S I Remizov, A V Andreev, V M Durleshter, S A Gabriel, O V Zasyadko","doi":"10.17116/hirurgia202404138","DOIUrl":"https://doi.org/10.17116/hirurgia202404138","url":null,"abstract":"<p><strong>Objective: </strong>To develop a method for direct transfistulous ultrasound in minimally invasive treatment of infected pancreatic necrosis.</p><p><strong>Material and methods: </strong>There were 148 patients with infected pancreatic necrosis between 2015 and 2019 at the Krasnodar City Clinical Hospital No. 2. Drainage with 28-32 Fr tubes was carried out at the first stage, endoscopic transfistulous sequestrectomy - at the second stage (19 (12.8%) patients). In 84 (56.8%) patients, we applied original diagnostic method (transfistulous ultrasonic assessment of inflammatory focus).</p><p><strong>Results: </strong>There were 3 accesses to omental bursa in 93 (62.8%) patients and 2 in 43 (29.1%) patients. We also performed 2 access to retroperitoneal space in 63 (42.6%) patients and 1 access in 38 (25.8%) cases. Transfistulous ultrasound was used once in 19 (22.6%) patients, twice in 28 (33.3%) and 3 times in 37 (44.1%) patients. Examination was not performed in 18 (12.2%) patients due to the following reasons: migration of drainage catheters - 5, non-rectilinear fistulous tract - 13. No complications were observed.</p><p><strong>Conclusion: </strong>Transfistulous ultrasound makes it possible to diagnose pathological changes in the pancreas and parapancreatic tissue at various stages of surgical treatment.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 4","pages":"38-43"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Choledochal cysts: surgical treatment in newborns and infants]. [胆总管囊肿:新生儿和婴儿的手术治疗]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia20240315
A B Alkhasov, A S Gurskaya, R R Bayazitov, O N Nakovkin, M A Sulavko, I V Karnuta, E V Ekimovskaya, I A Kyarimov, D M Akhmedova, A A Klepikova, S A Ratnikov, A P Fisenko

Objective: To improve postoperative outcomes in newborns and infants with choledochal cysts and to determine the indications for surgery.

Material and methods: There were 13 children aged 0-3 months with choledochal cyst who underwent reconstructive surgery between 2019 and 2023. In all children, choledochal cyst was associated with cholestasis. Acholic stool was observed in almost half of the group (n=7). All children underwent cyst resection and Roux-en-Y hepaticoenterostomy.

Results: Symptoms of cholestasis regressed in all patients. Mean surgery time was 128±27 min. There were no complications. Enteral feeding was started after 1-2 postoperative days, abdominal drainage was removed after 6.2±1.6 days. Mean length of hospital-stay was 16±3.7 days. Adequate bile outflow is one of the main principles. For this purpose, anastomosis with intact tissues of hepatic duct should be as wide as possible. Roux-en-Y loop should be at least 40-60 cm to prevent postoperative cholangitis.

Conclusion: Drug-resistant cholestasis syndrome and complicated choledochal cysts (cyst rupture, bile peritonitis) are indications for surgical treatment in newborns and infants. When forming Roux-en-Y hepaticoenterostomy, surgeon should totally excise abnormal tissues of the biliary tract to prevent delayed malignant transformation.

目的:改善患有胆总管囊肿的新生儿和婴儿的术后效果,并确定手术适应症:改善患有胆总管囊肿的新生儿和婴儿的术后效果,并确定手术适应症:2019年至2023年期间,13名0-3个月大的胆总管囊肿患儿接受了整形手术。所有患儿的胆总管囊肿均伴有胆汁淤积。几乎半数患儿(7 人)出现胆汁淤积便。所有患儿均接受了囊肿切除术和Roux-en-Y肝肠造口术:结果:所有患者的胆汁淤积症状均得到缓解。平均手术时间为 128±27 分钟。无并发症。术后1-2天开始肠内喂养,6.2±1.6天后拔除腹腔引流管。平均住院时间为(16±3.7)天。充分的胆汁流出是主要原则之一。为此,与肝管完整组织的吻合口应尽可能宽。Roux-en-Y环路至少应为40-60厘米,以防止术后胆管炎:结论:耐药胆汁淤积综合征和复杂性胆总管囊肿(囊肿破裂、胆汁性腹膜炎)是新生儿和婴儿手术治疗的适应症。在进行 Roux-en-Y 肝肠造口术时,外科医生应完全切除胆道的异常组织,以防止延迟恶变。
{"title":"[Choledochal cysts: surgical treatment in newborns and infants].","authors":"A B Alkhasov, A S Gurskaya, R R Bayazitov, O N Nakovkin, M A Sulavko, I V Karnuta, E V Ekimovskaya, I A Kyarimov, D M Akhmedova, A A Klepikova, S A Ratnikov, A P Fisenko","doi":"10.17116/hirurgia20240315","DOIUrl":"10.17116/hirurgia20240315","url":null,"abstract":"<p><strong>Objective: </strong>To improve postoperative outcomes in newborns and infants with choledochal cysts and to determine the indications for surgery.</p><p><strong>Material and methods: </strong>There were 13 children aged 0-3 months with choledochal cyst who underwent reconstructive surgery between 2019 and 2023. In all children, choledochal cyst was associated with cholestasis. Acholic stool was observed in almost half of the group (<i>n</i>=7). All children underwent cyst resection and Roux-en-Y hepaticoenterostomy.</p><p><strong>Results: </strong>Symptoms of cholestasis regressed in all patients. Mean surgery time was 128±27 min. There were no complications. Enteral feeding was started after 1-2 postoperative days, abdominal drainage was removed after 6.2±1.6 days. Mean length of hospital-stay was 16±3.7 days. Adequate bile outflow is one of the main principles. For this purpose, anastomosis with intact tissues of hepatic duct should be as wide as possible. Roux-en-Y loop should be at least 40-60 cm to prevent postoperative cholangitis.</p><p><strong>Conclusion: </strong>Drug-resistant cholestasis syndrome and complicated choledochal cysts (cyst rupture, bile peritonitis) are indications for surgical treatment in newborns and infants. When forming Roux-en-Y hepaticoenterostomy, surgeon should totally excise abnormal tissues of the biliary tract to prevent delayed malignant transformation.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 3","pages":"5-13"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Is there an alternative to Getz procedure for common bile duct disruption?] [是否有替代Getz手术治疗胆总管断裂的方法?]
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202406177
S V Dergal, V K Koryttsev, A V Mazokha, A Yu Shesterkin, O I Stakhanova

The authors present common bile duct reconstruction using the Kehr drainage.

作者介绍了使用 Kehr 引流管重建胆总管的情况。
{"title":"[Is there an alternative to Getz procedure for common bile duct disruption?]","authors":"S V Dergal, V K Koryttsev, A V Mazokha, A Yu Shesterkin, O I Stakhanova","doi":"10.17116/hirurgia202406177","DOIUrl":"https://doi.org/10.17116/hirurgia202406177","url":null,"abstract":"<p><p>The authors present common bile duct reconstruction using the Kehr drainage.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 6","pages":"77-80"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cavitary lung lesions in COVID-19 associated pneumonia: a single-center study of 40 cases]. [COVID-19 相关肺炎中的腔隙性肺部病变:对 40 例病例的单中心研究]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202406128
Z G Berikhanov, S N Avdeev, G V Neklyudova, Z M Merzhoeva, S A Ponomar, M S Goltseva

Objective: To demonstrate clinical features and outcomes in patients with cavitary lung lesions and COVID-19 associated pneumonia.

Material and methods: A retrospective analysis of electronic medical records of 8261 patients with COVID-19 was performed. We selected 40 patients meeting the inclusion criteria. Sex, age, hospital-stay, lung tissue lesion, comorbidities, treatment, methods of respiratory support, complications and outcomes were evaluated.

Results: Cavitary lung lesions were more common in men (67.5%). Age of patients ranged from 28 to 88 (mean 64.9±13.7) years. Hospital-stay in patients with cavitary lung lesions was 9-58 (median 27.5) days. There were 18 complications in 14 (35%) patients. Pneumothorax, isolated pneumomediastinum, pleural empyema, hemoptysis and sigmoid colon perforation were considered as complications of cavitary lung lesions. Nine (22.5%) patients died (5 of them with complications). Three patients died after surgical treatment. Long-term results were analyzed in 8 (25.8%) patients. Patients were followed-up for 3 months after discharge. Shrinkage of lesions occurred after 7-60 (mean 23) days, and complete obliteration of cavities came after 32 (range 14-90) days.

Conclusion: Cavitary lung lesions are a rare complication of COVID-19 pneumonia. There was no significant correlation of complications with age, sex, therapy, volume of lung lesions and non-invasive ventilation (NIV). Despite more common fatal outcomes in older patients undergoing NIV, the last one was prescribed exclusively due to disease progression and respiratory failure. Further research on this problem is necessary to identify possible risk factors of cavitary lung lesions.

摘要材料与方法:对 8261 例 COVID-19 患者的电子病历进行回顾性分析:对 8261 例 COVID-19 患者的电子病历进行回顾性分析。我们选择了 40 名符合纳入标准的患者。对患者的性别、年龄、住院时间、肺组织病变、合并症、治疗、呼吸支持方法、并发症和预后进行了评估:结果:空洞型肺部病变在男性中更为常见(67.5%)。患者年龄从 28 岁到 88 岁(平均 64.9±13.7)岁不等。腔隙性肺部病变患者的住院时间为 9-58 天(中位数为 27.5 天)。14名患者(35%)出现了18种并发症。气胸、孤立性气胸、胸腔积液、咯血和乙状结肠穿孔被视为肺空洞病变的并发症。9名(22.5%)患者死亡(其中5人有并发症)。3 名患者在手术治疗后死亡。对 8 例(25.8%)患者的长期结果进行了分析。患者出院后接受了 3 个月的随访。病变在 7-60 天(平均 23 天)后缩小,空洞在 32 天(14-90 天)后完全消失:结论:肺空洞病变是 COVID-19 肺炎的罕见并发症。并发症与年龄、性别、治疗、肺部病变体积和无创通气(NIV)无明显相关性。尽管接受无创通气治疗的老年患者更容易出现致命的并发症,但最后一种并发症完全是由于疾病进展和呼吸衰竭所致。有必要对这一问题进行进一步研究,以确定肺空洞病变的可能风险因素。
{"title":"[Cavitary lung lesions in COVID-19 associated pneumonia: a single-center study of 40 cases].","authors":"Z G Berikhanov, S N Avdeev, G V Neklyudova, Z M Merzhoeva, S A Ponomar, M S Goltseva","doi":"10.17116/hirurgia202406128","DOIUrl":"https://doi.org/10.17116/hirurgia202406128","url":null,"abstract":"<p><strong>Objective: </strong>To demonstrate clinical features and outcomes in patients with cavitary lung lesions and COVID-19 associated pneumonia.</p><p><strong>Material and methods: </strong>A retrospective analysis of electronic medical records of 8261 patients with COVID-19 was performed. We selected 40 patients meeting the inclusion criteria. Sex, age, hospital-stay, lung tissue lesion, comorbidities, treatment, methods of respiratory support, complications and outcomes were evaluated.</p><p><strong>Results: </strong>Cavitary lung lesions were more common in men (67.5%). Age of patients ranged from 28 to 88 (mean 64.9±13.7) years. Hospital-stay in patients with cavitary lung lesions was 9-58 (median 27.5) days. There were 18 complications in 14 (35%) patients. Pneumothorax, isolated pneumomediastinum, pleural empyema, hemoptysis and sigmoid colon perforation were considered as complications of cavitary lung lesions. Nine (22.5%) patients died (5 of them with complications). Three patients died after surgical treatment. Long-term results were analyzed in 8 (25.8%) patients. Patients were followed-up for 3 months after discharge. Shrinkage of lesions occurred after 7-60 (mean 23) days, and complete obliteration of cavities came after 32 (range 14-90) days.</p><p><strong>Conclusion: </strong>Cavitary lung lesions are a rare complication of COVID-19 pneumonia. There was no significant correlation of complications with age, sex, therapy, volume of lung lesions and non-invasive ventilation (NIV). Despite more common fatal outcomes in older patients undergoing NIV, the last one was prescribed exclusively due to disease progression and respiratory failure. Further research on this problem is necessary to identify possible risk factors of cavitary lung lesions.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 6","pages":"28-35"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy of prevention of recurrent laryngeal nerve injury in thyroid surgery]. [甲状腺手术中预防喉返神经损伤的效果]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202407185
R M Zakhokhov, T G Tlupova, I B Zhurtova, A A Mukaev, Z N Bakov, D A Teuvazhukova

Objective: To evaluate the effectiveness of prevention of recurrent laryngeal nerve injury depending on thyroid gland lesion and extent of surgery.

Material and methods: There were 2412 thyroid surgeries between 2000 and 2020. Patients were divided into the main group (1689 patients) and the control group (729 patients). Patients with nodular thyroid gland lesions prevailed in both groups (987 (58.4%) and 415 (56.9%), respectively). All ones underwent atraumatic extrafascial desection and thyroid resection (ultrasonic scalpel).

Results. t: He upper laryngeal nerve injury occurred in 35 cases (1.4%). The number of surgeries with thyroid remnant preservation was significantly lower in the main group. The number of procedures with subtotal thyroid resection and thyroidectomy increased by 2.4 times (from 414 to 1010 operations, p<0.05).

Conclusion: Improvement of surgical treatment of thyroid gland lesions consisting in new operative technique of recurrent laryngeal nerve isolation using ultrasonic scalpel reduces the incidence of recurrent laryngeal nerve injury from 2.3% to 1%. At the same time, the number of extended procedures in the main group significantly exceeded that in the control group (by 2.5 times).

目的:评估根据甲状腺病变和手术程度预防喉返神经损伤的有效性:评估根据甲状腺病变和手术范围预防喉返神经损伤的效果:2000 年至 2020 年间共进行了 2412 例甲状腺手术。将患者分为主要组(1689 例)和对照组(729 例)。两组患者均以甲状腺结节性病变为主(分别为987例(58.4%)和415例(56.9%))。所有患者均接受了创伤性筋膜外切除术和甲状腺切除术(超声刀):35例(1.4%)发生上喉神经损伤。保留甲状腺残留物的手术数量在主要组中明显较少。甲状腺次全切除术和甲状腺切除术的手术数量增加了 2.4 倍(从 414 例增加到 1010 例,P=0.9):使用超声刀隔离喉返神经的新手术技术改进了甲状腺病变的手术治疗,将喉返神经损伤的发生率从2.3%降至1%。同时,主要治疗组的延长手术次数明显超过对照组(2.5 倍)。
{"title":"[Efficacy of prevention of recurrent laryngeal nerve injury in thyroid surgery].","authors":"R M Zakhokhov, T G Tlupova, I B Zhurtova, A A Mukaev, Z N Bakov, D A Teuvazhukova","doi":"10.17116/hirurgia202407185","DOIUrl":"https://doi.org/10.17116/hirurgia202407185","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effectiveness of prevention of recurrent laryngeal nerve injury depending on thyroid gland lesion and extent of surgery.</p><p><strong>Material and methods: </strong>There were 2412 thyroid surgeries between 2000 and 2020. Patients were divided into the main group (1689 patients) and the control group (729 patients). Patients with nodular thyroid gland lesions prevailed in both groups (987 (58.4%) and 415 (56.9%), respectively). All ones underwent atraumatic extrafascial desection and thyroid resection (ultrasonic scalpel).</p><p><strong>Results. t: </strong>He upper laryngeal nerve injury occurred in 35 cases (1.4%). The number of surgeries with thyroid remnant preservation was significantly lower in the main group. The number of procedures with subtotal thyroid resection and thyroidectomy increased by 2.4 times (from 414 to 1010 operations, <i>p</i><0.05).</p><p><strong>Conclusion: </strong>Improvement of surgical treatment of thyroid gland lesions consisting in new operative technique of recurrent laryngeal nerve isolation using ultrasonic scalpel reduces the incidence of recurrent laryngeal nerve injury from 2.3% to 1%. At the same time, the number of extended procedures in the main group significantly exceeded that in the control group (by 2.5 times).</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 7","pages":"85-91"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Postoperative sternomediastinitis: morphology of lesion, treatment strategy]. [术后胸锁乳突炎:病变形态、治疗策略]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202407178
I A Vinokurov, Yu V Belov, D G Tagabilev, S A Yusupov

Objective: To analyze bone tissue damage at different stages of disease (El Oakley classification), treatment options for each clinical situation and results after each approach.

Material and methods: There were 45 patients with wound complications after cardiac surgery between October 2022 and September 2023. Thirty-eight (84.4%) patients underwent CABG, 7 (15.6%) patients - heart valve or aortic surgery. Mean age of patients was 68.1±10.3 years. There were 35 men (77.8%) and 10 women (22.2%). The first type was found in 11 (24.5%) patients, type 2-3 - 19 (42.2%), type 4 - 4 (8.8%), type 5 - 11 (24.5%) patients.

Results: Systemic inflammatory response syndrome was observed in 7 (36.8%) persons of the 1st group, 14 (73.7%) ones of the 2nd group, 4 (100%) patients of the 3rd group and 2 (18.2%) patients of the 4th group. C-reactive protein and procalcitonin increased in all patients with the highest values in groups 2 and 3. Redo soft tissue inflammation occurred in all groups after treatment. Mean incidence was 25%. Two (10.5%) patients died in the 2nd group and 1 (25%) patient in the 3rd group.

Conclusion: The modern classification of sternomediastinitis does not fully characterize severity of disease in a particular patient. Simultaneous debridement with wound closure demonstrates acceptable mortality (within 10%). The highest mortality rate was observed in patients with diffuse lesions of the sternum. Less aggressive treatment approaches are possible for stable anterior chest wall.

摘要分析不同疾病阶段的骨组织损伤(埃尔-奥克利分类)、每种临床情况下的治疗方案以及每种方法后的效果:2022年10月至2023年9月期间,45名患者在心脏手术后出现伤口并发症。其中 38 例(84.4%)患者接受了 CABG 手术,7 例(15.6%)患者接受了心脏瓣膜或主动脉手术。患者平均年龄为(68.1±10.3)岁。其中男性 35 人(77.8%),女性 10 人(22.2%)。11例(24.5%)患者为第一型,19例(42.2%)为第二至第三型,4例(8.8%)为第四型,11例(24.5%)为第五型:结果:第一组有 7 人(36.8%)、第二组有 14 人(73.7%)、第三组有 4 人(100%)、第四组有 2 人(18.2%)出现了全身炎症反应综合征。所有患者的 C 反应蛋白和降钙素原都有所增加,其中第 2 组和第 3 组的数值最高。所有组别在治疗后都出现了软组织炎症。平均发生率为 25%。第 2 组有 2 名(10.5%)患者死亡,第 3 组有 1 名(25%)患者死亡:结论:胸锁乳突炎的现代分类并不能完全描述特定患者的病情严重程度。同时进行清创和伤口闭合可降低死亡率(10%以内)。胸骨弥漫性病变患者的死亡率最高。对于病情稳定的前胸壁患者,可以采取不那么激进的治疗方法。
{"title":"[Postoperative sternomediastinitis: morphology of lesion, treatment strategy].","authors":"I A Vinokurov, Yu V Belov, D G Tagabilev, S A Yusupov","doi":"10.17116/hirurgia202407178","DOIUrl":"https://doi.org/10.17116/hirurgia202407178","url":null,"abstract":"<p><strong>Objective: </strong>To analyze bone tissue damage at different stages of disease (El Oakley classification), treatment options for each clinical situation and results after each approach.</p><p><strong>Material and methods: </strong>There were 45 patients with wound complications after cardiac surgery between October 2022 and September 2023. Thirty-eight (84.4%) patients underwent CABG, 7 (15.6%) patients - heart valve or aortic surgery. Mean age of patients was 68.1±10.3 years. There were 35 men (77.8%) and 10 women (22.2%). The first type was found in 11 (24.5%) patients, type 2-3 - 19 (42.2%), type 4 - 4 (8.8%), type 5 - 11 (24.5%) patients.</p><p><strong>Results: </strong>Systemic inflammatory response syndrome was observed in 7 (36.8%) persons of the 1<sup>st</sup> group, 14 (73.7%) ones of the 2<sup>nd</sup> group, 4 (100%) patients of the 3<sup>rd</sup> group and 2 (18.2%) patients of the 4<sup>th</sup> group. C-reactive protein and procalcitonin increased in all patients with the highest values in groups 2 and 3. Redo soft tissue inflammation occurred in all groups after treatment. Mean incidence was 25%. Two (10.5%) patients died in the 2<sup>nd</sup> group and 1 (25%) patient in the 3<sup>rd</sup> group.</p><p><strong>Conclusion: </strong>The modern classification of sternomediastinitis does not fully characterize severity of disease in a particular patient. Simultaneous debridement with wound closure demonstrates acceptable mortality (within 10%). The highest mortality rate was observed in patients with diffuse lesions of the sternum. Less aggressive treatment approaches are possible for stable anterior chest wall.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 7","pages":"78-84"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Khirurgiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1